Correction: Do optimal prognostic thresholds in continuous physiological variables really exist? Analysis of origin of apparent thresholds, with systematic review for peak oxygen consumption, ejection fraction and BNP (PLoS ONE (2014) 9:1 (e81699) DOI: 10.1371/journal.pone.0081699);Do optimal prognostic thresholds in continuous physiological variables really exist? Analysis of origin of apparent thresholds, with systematic review for peak oxygen consumption, ejection fraction and BNP

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Giannoni, Alberto ^a,b   Baruah, Resham ^a   Leong, Tora ^a   Rehman, Michaela B ^d   Pastormerlo, Luigi Emilio ^b   Harrell, Frank E ^e   Coats, Andrew J S ^a,c   Francis, Darrel P ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b Fondazione Monasterio   (Italy)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d POITIERS UNIVERSITY HOSPITAL   (France)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; OXYGEN;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL ARTICLE; CLINICAL DECISION MAKING; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; OXYGEN CONSUMPTION; PEAK OXYGEN CONSUMPTION; PREDICTION; PROGNOSIS; PUBLICATION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SIMULATION; SURVIVAL; SYSTEMATIC REVIEW;

HUMANS; NATRIURETIC PEPTIDE, BRAIN; OXYGEN CONSUMPTION; PROGNOSIS; REFERENCE VALUES; STROKE VOLUME;

EID: 84899618756     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105175     Document Type: Erratum

References (116)

1. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, et al (1991) Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83:778-86.
2. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, et al (1993) 24th Bethesda Conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization. J Am Coll Cardiol 22:21-31.
3. Banner NR, Bonser RS, Clark AL, Cowburn PJ, Gardner RS, et al (2011) UK guidelines for referral and assessment of adults for heart transplantation. Heart 97:1520-1527.
4. Szlachcic J, Massie BM, Kramer BL, Topic N, Tubau J (1985) Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 55:1037-42. (Pubitemid 15085359)
5. Likoff MJ, Chandler SL, Kay HR (1987) Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 59:634-81.
6. Van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman ML, Hillege H, et al (1992) Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 70:359-63.
7. Clark AL, Coats AJ (2000) Exercise endpoints in patients with chronic heart failure. Int J Cardiol. 73:61-6. (Pubitemid 30169200)
8. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology (2005) Eur Heart J 26:1115-40.
9. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2005) Circulation 112:e154-235.
10. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006 (2006) J Heart Lung Transplant 25:1024-42.
11. Di Salvo TG, Mathier M, Semigran MJ, Dec GW (1995) Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 25:1143-53.
12. Isnard R, Pousset F, Trochu J, Chafirovskaïa O, Carayon A, et al (2000) Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure. Am J Cardiol 86:417-21. (Pubitemid 30628608)
13. Rostagno C, Olivo G, Comeglio M, Boddi V, Banchelli M, et al (2003) Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Eur J Heart Fail 5:247-52. (Pubitemid 37011852)
14. Niebauer J, Clark AL, Anker SD, Coats AJ (1999) Three year mortality in heart failure patients with very low left ventricular ejection fractions. Int J Cardiol 70:245-7. (Pubitemid 29397475)
15. Mehta D, Saksena S, Krol RB (1992) Survival of implantable cardioverter-defibrillator recipients: role of left ventricular function and its relationship to device use. Am Heart J 124:1608-14. (Pubitemid 23003599)
16. Omland T, Bonarjee VV, Lie RT, Caidahl K (1995) Neurohumoral measurements as indicators of long-term prognosis after acute myocardial infarction. Am J Cardiol 76:230-5.
17. Masson S, Latini R, Anand IS, Vago T, Angelici L, et al (2006) Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. Clin Chem 52:1528-38. (Pubitemid 44148316)
18. Bertinchant JP, Combes N, Polge A, Fabbro-Peray P, Raczka F, et al (2005) Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine. Clin Chim Acta 352:143-53. (Pubitemid 40093866)
19. Sun T, Wang L, Zhang Y (2007) Prognostic value of B-type natriuretic peptide in patients with chronic and advanced heart failure. Intern Med J 37:168-71.
20. Cohen-Solal A, Logeart D, Huang B, Cai D, Nieminen MS, et al (2009) Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. J Am Coll Cardiol 53:2343-8.
21. Peterson LR, Schechtman KB, Ewald GA, Geltman EM, de las Fuentes L, et al (2003) Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers. J Heart Lung Transplant 22:1141-8. (Pubitemid 37206570)
22. Francis DP, Shamim W, Davies LC, Piepoli MF, Ponikowski P, et al (2000) Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J 21:154-61. (Pubitemid 30072630)
23. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, et al (1986) Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 314:1547-52. (Pubitemid 16114684)
24. Parameshwar J, Keegan J, Sparrow J, Sutton GC, Poole-Wilson PA (1992) Predictors of prognosis in severe chronic heart failure. Am Heart J 123:421-6.
25. Saxon LA, Stevenson WG, Middlekauff HR, Fonarow G, Woo M, et al (1993) Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 72:62-5. (Pubitemid 23184364)
26. Chomsky DB, Lang CC, Rayos GH, Shyr Y, Yeoh TK, et al (1996) Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates. Circulation 94:3176-3.
27. Cohen-Solal A, Barnier P, Pessione F, Seknadji P, Logeart D, et al (1997) Comparison of the long-term prognostic value of peak exercise oxygen pulse and peak oxygen uptake in patients with chronic heart failure. Heart 78:572-6. (Pubitemid 28034206)
28. Metra M, Faggiano P, D'Aloia A, Nodari S, Gualeni A, et al (1999) Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol 33:943-50.
29. Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV (2000) The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol 36:2126-31.
30. Davies LC, Francis DP, Piepoli M, Scott AC, Ponikowski P, et al (2000) Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification. Heart 83:147-51. (Pubitemid 30305539)
31. Hansen A, Haass M, Zugck C, Krueger C, Unnebrink K, et al (2001) Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol 37:1049-55. (Pubitemid 32217605)
32. Gitt AK, Wasserman K, Kilkowski C, Kleemann T, Kilkowski A, et al (2002) Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation 106:3079-84. (Pubitemid 35440292)
33. O'Neill JO, Young JB, Pothier CE, Lauer MS (2005) Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation 111:2313-8. (Pubitemid 40647066)
34. Rossi A, Cicoira M, Bonapace S, Golia G, Zanolla L, et al (2007) Left atrial volume provides independent and incremental information compared with exercise tolerance parameters in patients with heart failure and left ventricular systolic dysfunction. Heart 93:1420-5. (Pubitemid 351480145)
35. Sachdeva A, Horwich TB, Fonarow GC (2010) Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure. Am J Cardiol 106:830-5.
36. Robbins M, Francis G, Pashkow FJ, Snader CE, Hoercher K, et al (1999) Ventilatory and heart rate responses to exercise : better predictors of heart failure mortality than peak oxygen consumption. Circulation 100:2411-7.
37. Williams SG, Cooke GA, Wright DJ, Snader CE, Hoercher K, et al (2001) Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J 2001;22:1496-503. (Pubitemid 32769177)
38. Ponikowski P, Chua TP, Anker SD, Francis DP, Doehner W, et al (2001) Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 104:544-9. (Pubitemid 32738123)
39. Mejhert M, Linder-Klingsell E, Edner M, Kahan T, Persson H (2002) Ventilatory variables are strong prognostic markers in elderly patients with heart failure. Heart 88:239-43. (Pubitemid 34913503)
40. Schalcher C, Rickli H, Brehm M, Weilenmann D, Oechslin E, et al (2003) Prolonged oxygen uptake kinetics during low-intensity exercise are related to poor prognosis in patients with mild-to-moderate congestive heart failure. Chest 124:580-6. (Pubitemid 37000137)
41. Nanas SN, Nanas JN, Sakellariou DC, Dimopoulos SK, Drakos SG, et al (2006) VE/VCO2 slope is associated with abnormal resting haemodynamics and is a predictor of long-term survival in chronic heart failure. Eur J Heart Fail 8:420-7. (Pubitemid 43853088)
42. Bard RL, Gillespie BW, Clarke NS, Egan TG, Nicklas JM (2006) Determining the best ventilatory efficiency measure to predict mortality in patients with heart failure. J Heart Lung Transplant 25:589-95.
43. Guazzi M, Raimondo R, Vicenzi M, Arena R, Proserpio C, et al (2007) Exercise oscillatory ventilation may predict sudden cardiac death in heart failure patients. J Am Coll Cardiol 50:299-308.
44. Guazzi M, Arena R, Ascione A, Piepoli M, Guazzi MD (2007) Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: an unfavorable combination with high prognostic value. Am Heart J 153:859-67. (Pubitemid 46602158)
45. Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, et al (2008) The partial pressure of resting end-tidal carbon dioxide predicts major cardiac events in patients with systolic heart failure. Am Heart J 156:982-8.
46. Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, et al (2010) The prognostic value of the heart rate response during exercise and recovery in patients with heart failure: influence of beta-blockade. Int J Cardiol 138:166-73.
47. Izawa KP, Watanabe S, Osada N, Kasahara Y, Yokoyama H, et al (2009) Handgrip strength as a predictor of prognosis in Japanese patients with congestive heart failure. Eur J Cardiovasc Prev Rehabil 16:21-7.
48. Itoh A, Saito M, Haze K, Hiramori K, Kasagi F (1992) Prognosis of patients with congestive heart failure: its determinants in various heart diseases in Japan. Intern Med 31:304-9.
49. Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ (1994) Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation 90:2772-9.
50. Andreas S, Hagenah G, Moller C, Werner GS, Kreuzer H (1996) Cheyne-Stokes respiration and prognosis in congestive heart failure. Am J Cardiol 78:1260-4. (Pubitemid 126657205)
51. Giannuzzi P, Temporelli PL, Bosimini E, Silva P, Imparato A, et al (1996) Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol 28:383-90. (Pubitemid 26274332)
52. Szabó BM, van Veldhuisen DJ, van der Veer N, Brouwer J, De Graeff PA, et al (1997) Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 79:978-80.
53. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, et al (1997) Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349:1050-3. (Pubitemid 27158249)
54. Wijbenga JA, Balk AH, Meij SH, Simoons ML, Malik M (1998) Heart rate variability index in congestive heart failure: relation to clinical variables and prognosis. Eur Heart J 19:1719-24. (Pubitemid 28524192)
55. Metra M, Faggiano P, D'Aloia A, Nodari S, Gualeni A, et al (1999) Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol 33:943-50.
56. Isnard R, Pousset F, Trochu J, Chafirovskaïa O, Carayon A, et al (2000) Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure. Am J Cardiol 86:417-21. (Pubitemid 30628608)
57. Ghio S, Recusani F, Klersy C, Sebastiani R, Laudisa ML, et al (2000) Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 85:837-42. (Pubitemid 30157849)
58. Corrà U, Mezzani A, Bosimini E, Scapellato F, Imparato A, et al (2002) Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. Am Heart J 143:418-26.
59. Szachniewicz J, Petruk-Kowalczyk J, Majda J, Majda J, Kaczmarek A, et al (2003) Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 90:303-8. (Pubitemid 37087891)
60. Guazzi M, Reina G, Tumminello G, Guazzi MD (2005) Exercise ventilation inefficiency and cardiovascular mortality in heart failure: the critical independent prognostic value of the arterial CO2 partial pressure. Eur Heart J 26:472-80. (Pubitemid 40314763)
61. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, et al (2005) Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112:1756-62. (Pubitemid 41372115)
62. Jünger J, Schellberg D, Müller-Tasch T, Raupp G, Zugck C, et al (2005) Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail 7:261-7.
63. Rossi A, Cicoira M, Bonapace S, Golia G, Zanolla L, et al (2007) Left atrial volume provides independent and incremental information compared with exercise tolerance parameters in patients with heart failure and left ventricular systolic dysfunction. Heart 93:1420-5. (Pubitemid 351480145)
64. Arslan S, Erol MK, Gundogdu F, Sevimli S, Aksakal E, et al (2007) Prognostic value of 6-minute walk test in stable outpatients with heart failure. Tex Heart Inst J 34:166-9. (Pubitemid 47066590)
65. Guazzi M, Arena R, Ascione A, Piepoli M, Guazzi MD (2007) Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: an unfavorable combination with high prognostic value. Am Heart J 153:859-67. (Pubitemid 46602158)
66. von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, et al (2007) Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J Am Coll Cardiol 50:1973-80 (Pubitemid 350046336)
67. Smilde TD, van Veldhuisen DJ, van den Berg MP (2009) Prognostic value of heart rate variability and ventricular arrhythmias during 13-year follow-up in patients with mild to moderate heart failure. Clin Res Cardiol 98:233-9.
68. McDonagh TA, Cunningham AD, Morrison CE, McMurray JJ, Ford I, et al. (2001) Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 86:21-6. (Pubitemid 32977774)
69. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, et al (2002) Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 105:186-93. (Pubitemid 34084317)
70. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA (2003) N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24:1735-43. (Pubitemid 37236862)
71. Martínez-Sellés M, García Robles JA, Prieto L, Domínguez Muñoa M, Frades E, et al (2003) Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure. Eur Heart J 24:2046-53.
72. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H (2011) Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan-first report from the CHART-2 study. Circ J 75:823-33.
73. Petersson M, Friberg P, Eisenhofer G, Lambert G, Rundqvist B (2005) Longterm outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J 26:906-13. (Pubitemid 40676571)
74. Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, et al (2006) Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47:456-63. (Pubitemid 43063271)
75. Nishio Y, Sato Y, Taniguchi R, Shizuta S, Doi T, et al (2007) Cardiac troponin T vs other biochemical markers in patients with congestive heart failure. Circ J 71:631-5. (Pubitemid 46683349)
76. Dini FL, Conti U, Fontanive P, Andreini D, Banti S, et al (2007) Right ventricular dysfunction is a major predictor of outcome in patients with moderate to severe mitral regurgitation and left ventricular dysfunction. Am Heart J 154:172-9. (Pubitemid 46920480)
77. Whalley GA, Wright SP, Pearl A, Gamble GD, Walsh HJ, et al (2008) Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community. Eur Heart J 29:509-16. (Pubitemid 351264193)
78. Dini FL, Fontanive P, Panicucci E, Andreini D, Chella P, et al. (2008) Prognostic significance of tricuspid annular motion and plasma NT-proBNP in patients with heart failure and moderate-to-severe functional mitral regurgitation. Eur J Heart Fail. 10:573-80.
79. Parissis JT, Farmakis D, Nikolaou M, Birmpa D, Bistola V, et al (2009) Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up study. Eur J Heart Fail 11:967-72.
80. Omland T, Aakvaag A, Bonarjee VV, Caidahl K, Lie RT, et al (1996) Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93:1963-9.
81. Yu CM, Sanderson JE (1999) Plasma brain natriuretic peptide: an independent predictor of cardiovascular mortality in acute heart failure. Eur J Heart Fail 1:59-65. (Pubitemid 30074676)
82. Bettencourt P, Friões F, Azevedo A, Dias P, Pimenta J, et al (2004) Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure. Int J Cardiol 93:45-8.
83. de Groote P, Soudan B, Lamblin N, Rouaix-Emery N, Mc Fadden E, et al (2004) Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure? Am Heart J 148:349-55. (Pubitemid 39092806)
84. Hülsmann M, Berger R, Mörtl D, Gore O, Meyer B, et al (2005) Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide. Eur J Heart Fail 7:552-6.
85. Watanabe J, Shiba N, Shinozaki T, Koseki Y, Karibe A, et al (2005) Prognostic value of plasma brain natriuretic peptide combined with left ventricular dimensions in predicting sudden death of patients with chronic heart failure. J Card Fail 11:50-5. (Pubitemid 40215314)
86. Lamblin N, Mouquet F, Hennache B, Dagorn J, Susen S, et al (2005) High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J 26:2245-50. (Pubitemid 41541387)
87. Bertinchant JP, Combes N, Polge A, Fabbro-Peray P, Raczka F, et al (2005) Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine. Clin Chim Acta 352:143-53. (Pubitemid 40093866)
88. Horwich TB, Hamilton MA, Fonarow GC (2006) B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol 47:85-90. (Pubitemid 43005169)
89. Frantz RP, Lowes BD, Grayburn PA, White M, Krause-Steinrauf H, et al (2007) Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST). J Card Fail. 13:437-44. (Pubitemid 47176927)
90. Christ M, Thuerlimann A, Laule K, Klima T, Hochholzer W, et al (2007) Long-term prognostic value of B-type natriuretic peptide in cardiac and non-cardiac causes of acute dyspnoea. Eur J Clin Invest 37:834-41. (Pubitemid 350029207)
91. Dhaliwal AS, Deswal A, Pritchett A, Aguilar D, Kar B, et al (2009) Reduction in BNP levels with treatment of decompensated heart failure and future clinical events. J Card Fail 15:293-9.
92. Moertl D, Berger R, Hammer A, Huelsmann M, Hutuleac R, et al (2009) B-type natriuretic peptide predicts benefit from a home-based nurse care in chronic heart failure. J Card Fail 15:233-40.
93. Niessner A, Hohensinner PJ, Rychli K, Neuhold S, Zorn G, et al (2009) Prognostic value of apoptosis markers in advanced heart failure patients. Eur Heart J 30:789-96.
94. El-Saed A, Voigt A, Shalaby A (2009) Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy. Clin Cardiol 32:E33-8.
95. Sachdeva A, Horwich TB, Fonarow GC (2010) Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure. Am J Cardiol 106:830-5.
96. Voors AA, von Haehling S, Anker SD, Hillege HL, Struck J, et al (2009) C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study. Eur Heart J 30:1187-94.
97. Roul G, Moulichon ME, Bareiss P, Gries P, Koegler A, et al (1995) Prognostic factors of chronic heart failure in NYHA class II or III: value of invasive exercise haemodynamic data. Eur Heart J 16:1387-98.
98. Rossi A, Cicoira M, Bonapace S, Golia G, Zanolla L, et al (2007) Left atrial volume provides independent and incremental information compared with exercise tolerance parameters in patients with heart failure and left ventricular systolic dysfunction. Heart 93:1420-5. (Pubitemid 351480145)
99. Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA (2006) Impact of time past exercise testing on prognostic variables in heart failure. Int J Cardiol 106:88-94. (Pubitemid 41728915)
100. Royston P, Altman DG, Sauerbrei W (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25:127-41. (Pubitemid 43136953)
101. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-63. (Pubitemid 41821197)
102. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, et al (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112:e154-235.
103. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10:933-89.
104. Altman DG, Lausen B, Sauerbrei W and Schumacher M (1994) Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. Journal of the National Cancer Institute 86:829-835. (Pubitemid 2100935)
105. Hilsenbeck SG, Clark GM and McGuire WL (1992) Why do so many prognostic factors fail to pan out? Breast Cancer Research and Treatment 22:197-206.
106. Schulgen G, Lausen B, Olsen JH and Schumacher M (1994) Outcome-oriented cutpoints in analysis of quantitative exposures, American Journal of Epidemiology 140:172-184. (Pubitemid 24205814)
107. Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, et al (2013) An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J In press.
108. Raphael CE, Whinnett ZI, Davies JE, Fontana M, Ferenczi EA, et al (2009) Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart 95:56-62.
109. Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, et al (2007) Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med 167:1998-2005. (Pubitemid 47606641)
110. Pfister R, Diedrichs H, Schiedermair A, Rosenkranz S, Hellmich M, et al (2008) Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients. Eur J Heart Fail 10:315-20.
111. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, et al (1996) Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med 335:1333-41. (Pubitemid 26360451)
112. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P (2004) Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159:882-90. (Pubitemid 38657490)
113. Karvanen J, Harrell FE Jr (2009) Visualizing covariates in proportional hazards model. Stat Med 28:1957-66.
114. Royston P, Altman DG, Sauerbrei W (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25:127-41. (Pubitemid 43136953)
115. Wainer H (2006) Finding what is not there through the unfortunate binning of results: The Mendel effect. Chance 19:49-56.
116. Harrell FE Jr, Margolis PA, Gove S, Mason KE, Mulholland EK, et al (1998) Development of a clinical prediction model for an ordinal outcome: the World Health Organization Multicentre Study of Clinical Signs and Etiological agents of Pneumonia, Sepsis and Meningitis in Young Infants. WHO/ARI Young Infant Multicentre Study Group. Stat Med 17:909-44. (Pubitemid 28185168)